Fundraising Fox
Link Immunotherapeutics
Seattle, US · Founded 2019 · Delaware corporation · 3 employees on LinkedIn · 1 known investors
Find your way into Link Immunotherapeutics
Sign up to see every warm intro you have to Link Immunotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Link Immunotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MD
Meininger DavidNamed on SEC filing
Board
RU
EV
DO
Daniel O'ConnellBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$14.3M disclosed across 1 round · 2021
▶$14.3MraisedApr 2021 · 9 investors · OtherRule 506(b)
▶$14.3MraisedApr 2021 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel O'ConnellDirector
- Meininger DavidExecutive Officer, Director, Promoter
- Roger UlrichDirector
- Edward van WezelDirector
- Offering amount
- $17.3M
- Amount sold
- $14.3M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Link Immunotherapeutics's investors?
- Link Immunotherapeutics's investors include BioGeneration Ventures.
- How much funding has Link Immunotherapeutics raised?
- Link Immunotherapeutics has disclosed $14.3M raised across 1 round.
- Where is Link Immunotherapeutics headquartered?
- Link Immunotherapeutics is headquartered in Seattle, US.